EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische StudieOpen Access · CC BY 4.0

PATIENT-REPORTED OUTCOMES AFTER SURGERY FOR PROLIFERATIVE VITREORETINOPATHY: POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL

Rodrigo Anguita, Lorenzo Ferro Desideri, Janice Roth, Ines Schumacher, Philip Banerjee, Martin Zinkernagel, David G Charteris

Ophthalmologica · 2026

DOI: 10.1159/000550679 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Ophthalmologica, 2026. Verfasst von Rodrigo Anguita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Moorfields Eye Hospital NHS Foundation Trust, London, UK, rodrigoanguita@gmail.com. Hauptthemen laut MEDLINE: Vitreoretinopathy, Proliferative, Vitrectomy, Visual Acuity, Quality of Life. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Proliferative vitreoretinopathy (PVR) is the leading cause of surgical failure in rhegmatogenous retinal detachment (RRD) and is associated with poor visual prognosis. We aimed to report changes in VFQ-25 and SF-36 tests following surgery for PVR-RRD and identify clinical and demographic factors associated with recovery.

Methods

This is a post-hoc analysis of a phase IIIb randomised, participant-masked clinical trial evaluating slow-release dexamethasone in PVR-RRD. Patients underwent pars plana vitrectomy with silicone oil tamponade. Vision-related QOL was assessed using VFQ-25, and SF-36 test, at baseline, 6 months, and 12 months postoperatively. VFQ-25 subscales and SF-36 domains were analysed descriptively and with non-parametric paired tests; associations with best-corrected visual acuity (BCVA, logMAR) and other variables were assessed using Spearman correlation and non-parametric tests.

Results

A total of 139 patients were included (mean age 61 years; 60% male). VFQ-25 total score improved from a median of 65.5 at baseline to 70 at 12 months (p=0.0004). SF-36 total score improved from 68 to 77.5 at 12 months (p=0.006). Worse 12-month BCVA correlated with lower VFQ-25 (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitreoretinopathy, ProliferativeVitrectomyVisual AcuityQuality of LifePatient Reported Outcome MeasuresDexamethasoneEndotamponadeHumansFemaleMaleMiddle AgedFollow-Up StudiesGlucocorticoidsDouble-Blind MethodSilicone OilsTreatment OutcomeRetinal DetachmentAged

Stichwörter der Autor:innen

Patient-reported outcomesProliferative vitreoretinopathyQuality of lifeRetinal detachmentRhegmatogenous retinal detachmentVitrectomy

Substanzen

DexamethasoneGlucocorticoidsSilicone Oils

Autor:innen und Institutionen

  • Moorfields Eye Hospital NHS Foundation Trust, London, UK, rodrigoanguita@gmail.com.
  • Department of Ophthalmology, Inselspital, University Hospital of Bern, Bern, Switzerland, rodrigoanguita@gmail.com.
  • Department of Ophthalmology, Inselspital, University Hospital of Bern, Bern, Switzerland.
  • Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Department of Ophthalmology, Frimley Park Hospital NHS Foundation Trust, Frimley, UK.

Zitieren

APA

Anguita, R., Ferro Desideri, L., Roth, J., Schumacher, I., Banerjee, P., Zinkernagel, M., & Charteris, D. G. (2026). PATIENT-REPORTED OUTCOMES AFTER SURGERY FOR PROLIFERATIVE VITREORETINOPATHY: POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. Ophthalmologica. https://doi.org/10.1159/000550679

Vancouver

Anguita R, Ferro Desideri L, Roth J, Schumacher I, Banerjee P, Zinkernagel M, et al. PATIENT-REPORTED OUTCOMES AFTER SURGERY FOR PROLIFERATIVE VITREORETINOPATHY: POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. Ophthalmologica. 2026. doi:10.1159/000550679

BibTeX
@article{Anguita2026,
  author = {Anguita, Rodrigo and Ferro Desideri, Lorenzo and Roth, Janice and Schumacher, Ines and Banerjee, Philip and Zinkernagel, Martin and Charteris, David G},
  title = {PATIENT-REPORTED OUTCOMES AFTER SURGERY FOR PROLIFERATIVE VITREORETINOPATHY: POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL},
  journal = {Ophthalmologica},
  year = {2026},
  doi = {10.1159/000550679}
}
Kostenlos starten →